The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial
The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial
Authors
Keywords
The trial was registered with the South African National Clinical Trials Register (number DoH 27-1108-2525) and ClinicalTrials.gov (NCT02109874), H4:IC31, Mycobacterium tuberculosis, Vaccine, Adults, Clinical trial
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now